How much is Aeglea BioTherapeutics worth in 2026?

Aeglea BioTherapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Aeglea BioTherapeutics raised?

Aeglea BioTherapeutics has raised N/A in total funding across 1 funding rounds.

Aeglea BioTherapeutics

Drug Discovery

Aeglea BioTherapeutics valuation and funding history | Last updated: June 22, 2023 | 1 funding rounds

Current Valuation

N/A

As of June 22, 2023

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$210.0M

Last Funding

Jun 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
June 22, 2023	PIPE	$210.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Aeglea BioTherapeutics is currently valued at N/A as of June 22, 2023.

Track Aeglea BioTherapeutics Valuation Updates

Get notified when Aeglea BioTherapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Aeglea BioTherapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Aeglea BioTherapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Aeglea BioTherapeutics Worth in 2026?

Aeglea BioTherapeutics is a leading private company in the Drug Discovery sector. Track Aeglea BioTherapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Aeglea BioTherapeutics Valuation is Determined

Private company valuations like Aeglea BioTherapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.